Schroder Investment Management Group Sells 108,841 Shares of Encompass Health Corporation $EHC

Schroder Investment Management Group decreased its position in shares of Encompass Health Corporation (NYSE:EHC) by 22.4% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 377,943 shares of the company’s stock after selling 108,841 shares during the quarter. Schroder Investment Management Group owned approximately 0.38% of Encompass Health worth $47,572,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Tectonic Advisors LLC boosted its position in Encompass Health by 1.6% during the third quarter. Tectonic Advisors LLC now owns 5,337 shares of the company’s stock worth $678,000 after purchasing an additional 82 shares during the period. Global Retirement Partners LLC lifted its stake in shares of Encompass Health by 23.0% during the 3rd quarter. Global Retirement Partners LLC now owns 449 shares of the company’s stock valued at $57,000 after buying an additional 84 shares in the last quarter. EP Wealth Advisors LLC boosted its holdings in Encompass Health by 2.4% in the 2nd quarter. EP Wealth Advisors LLC now owns 3,694 shares of the company’s stock worth $453,000 after buying an additional 88 shares during the period. Natural Investments LLC grew its stake in Encompass Health by 1.2% in the 3rd quarter. Natural Investments LLC now owns 7,808 shares of the company’s stock valued at $991,000 after buying an additional 89 shares in the last quarter. Finally, TD Private Client Wealth LLC lifted its position in shares of Encompass Health by 1.1% during the third quarter. TD Private Client Wealth LLC now owns 8,216 shares of the company’s stock worth $1,044,000 after acquiring an additional 91 shares in the last quarter. 97.25% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other Encompass Health news, CEO Mark J. Tarr sold 150,000 shares of the business’s stock in a transaction that occurred on Wednesday, February 11th. The shares were sold at an average price of $111.64, for a total transaction of $16,746,000.00. Following the completion of the transaction, the chief executive officer owned 377,070 shares in the company, valued at $42,096,094.80. The trade was a 28.46% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Treasurer Edmund Fay sold 11,937 shares of the stock in a transaction that occurred on Monday, March 9th. The shares were sold at an average price of $107.00, for a total transaction of $1,277,259.00. Following the completion of the sale, the treasurer directly owned 89,325 shares in the company, valued at approximately $9,557,775. This represents a 11.79% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 2.10% of the stock is owned by insiders.

Encompass Health Trading Down 1.7%

NYSE EHC opened at $106.75 on Wednesday. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.08 and a current ratio of 1.08. The firm has a market cap of $10.61 billion, a price-to-earnings ratio of 19.27, a PEG ratio of 2.08 and a beta of 0.71. The firm has a 50 day simple moving average of $103.92 and a 200-day simple moving average of $113.37. Encompass Health Corporation has a one year low of $92.53 and a one year high of $127.99.

Encompass Health (NYSE:EHC) last released its earnings results on Thursday, February 5th. The company reported $1.46 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.29 by $0.17. The firm had revenue of $3.09 billion during the quarter, compared to analyst estimates of $1.54 billion. Encompass Health had a return on equity of 18.20% and a net margin of 9.54%.Encompass Health’s revenue was up 9.9% compared to the same quarter last year. During the same period last year, the business posted $1.17 earnings per share. Encompass Health has set its FY 2026 guidance at 5.810-6.100 EPS. Equities research analysts anticipate that Encompass Health Corporation will post 4.8 EPS for the current fiscal year.

Encompass Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, April 15th. Investors of record on Wednesday, April 1st will be issued a $0.19 dividend. The ex-dividend date of this dividend is Wednesday, April 1st. This represents a $0.76 annualized dividend and a yield of 0.7%. Encompass Health’s dividend payout ratio (DPR) is 13.72%.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on EHC. Wall Street Zen upgraded Encompass Health from a “hold” rating to a “buy” rating in a research note on Sunday, January 18th. Zacks Research lowered Encompass Health from a “strong-buy” rating to a “hold” rating in a report on Wednesday, November 19th. Finally, Barclays upped their price target on Encompass Health from $150.00 to $153.00 and gave the company an “overweight” rating in a research report on Friday, February 6th. Two investment analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus price target of $143.29.

Encompass Health Company Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.